共 168 条
[1]
Randolph AG(2003)The feasibility of conducting clinical trials in infants and children with acute respiratory failure Am J Respir Crit Care Med 167 1334-1340
[2]
Meert KL(1988)Adult respiratory distress syndrome in pediatric patients. I. Clinical aspects, pathophysiology, pathology, and mechanisms of lung injury J Pediatr 112 169-180
[3]
O'Neil ME(1999)Abnormal surfactant composition and activity in severe bronchiolitis Acta Paediatr 88 942-946
[4]
Hanson JH(1996)Surfactant abnormalities in infants with severe viral bronchiolitis Arch Dis Child 75 133-136
[5]
Luckett PM(1991)A controlled trial of synthetic surfactant in infants weighing 1250 g or more with respiratory distress syndrome. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group N Engl J Med 325 1696-1703
[6]
Arnold JH(1996)Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome. Exosurf Acute Respiratory Distress Syndrome Sepsis Study Group N Engl J Med 334 1417-1421
[7]
Gedeit RG(1997)Bovine surfactant therapy for patients with acute respiratory distress syndrome Am J Respir Crit Care Med 155 1309-1315
[8]
Cox PN(2003)Treatment of acute respiratory distress syndrome with recombinant surfactant protein C surfactant Am J Respir Crit Care Med 167 1562-1566
[9]
Roberts JS(1994)Safety and potential efficacy of an aerosolized surfactant in human sepsis-induced adult respiratory distress syndrome JAMA 272 1433-1438
[10]
Venkataraman ST(1997)Exogenous surfactant therapy for pediatric patients with the acute respiratory distress syndrome Can Respir J 4 21-26